Tetrandrine induces apoptosis and triggers a caspase cascade in U2-OS and MG-63 cells through the intrinsic and extrinsic pathways

Molecular Medicine Reports

Volumn 9, Issue 1, 2014, Pages 345-349

  Tao, Li Jiang ^a   Zhou, Xin Die ^a   Shen, Cheng Chun ^a   Liang, Cheng Zhen ^a   Liu, Bing ^a   Tao, Yiqing ^a   Tao, Hui Min ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase; Extrinsic pathway; Intrinsic pathway; Osteosarcoma; Tetrandrine

Indexed keywords

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; BCL-2-ASSOCIATED X PROTEIN; BENZYLISOQUINOLINES; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CASPASES; CELL LINE, TUMOR; CYTOCHROMES C; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 84893827975     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1761     Document Type: Article

References (31)

1. Lin YT, Huang AC, Kuo CL, et al: Induction of cell cycle arrest and apoptosis in human osteosarcoma U-2 OS cells by Solanum lyratum extracts. Nutr Cancer 65: 469-479, 2013.
2. Liang CZ, Zhang X, Li H, et al: Gallic acid induces the apoptosis of human osteosarcoma cells in vitro and in vivo via the regulation of mitogen-activated protein kinase pathways. Cancer Biother Radiopharm 27: 701-710, 2012.
3. Cho HJ, Lee TS, Park JB, et al: Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression. J Biochem Mol Biol 40: 1069-1076, 2007.
4. Huang G, Mills L and Worth LL: Expression of human glutathione S-transferase P1 mediates the chemosensitivity of osteosarcoma cells. Mol Cancer Ther 6: 1610-1619, 2007.
5. Zhang B, Shi ZL, Liu B, Yan XB, Feng J and Tao HM: Enhanced anticancer effect of gemcitabine by genistein in osteosarcoma: the role of Akt and nuclear factor-κB. Anticancer Drugs 21: 288-296, 2010.
6. Posthumadeboer J, van Egmond PW, Helder MN, et al: Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin. Oncotarget 3: 1169-1181, 2012.
7. Zhang Y, Wei RX, Zhu XB, Cai L, Jin W and Hu H: Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro. Anticancer Drugs 23: 212-219, 2012.
8. Wu HY, Lin TK, Kuo HM, et al: Phyllanthus urinaria induces apoptosis in human osteosarcoma 143B cells via activation of Fas/FasL-and mitochondria-mediated pathways. Evid Based Complement Alternat Med 2012: 1-13, 2012.
9. Teh BS, Chen P, Lavin MF, Seow WK and Thong YH: Demonstration of the induction of apoptosis (programmed cell death) by tetrandrine, a novel anti-inflammatory agent. Int J Immunopharmacol 13: 1117-1126, 1991.
10. Lai YL, Chen YJ, Wu TY, et al: Induction of apoptosis in human leukemic U937 cells by tetrandrine. Anticancer Drugs 9: 77-81, 1998.
11. Dong Y, Yang MM and Kwan CY: In vitro inhibition of proliferation of HL-60 cells by tetrandrine and coriolus versicolor peptide derived from Chinese medicinal herbs. Life Sci 60: PL135-140, 1997.
12. Cho HS, Chang SH, Chung YS, et al: Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells. J Vet Sci 10: 23-28, 2009.
13. He BC, Gao JL, Zhang BQ, et al: Tetrandrine inhibits Wnt/β-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol Pharmacol 79: 211-219, 2011.
14. Yoo SM, Oh SH, Lee SJ, et al: Inhibition of proliferation and induction of apoptosis by tetrandrine in HepG2 cells. J Ethnopharmacol 81: 225-229, 2002.
15. Wei J, Liu B, Wang L, Qian X, Ding Y and Yu L: Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines. Cancer Chemother Pharmacol 60: 703-711, 2007.
16. Meng LH, Zhang H, Hayward L, Takemura H, Shao RG and Pommier Y: Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1. Cancer Res 64: 9086-9092, 2004.
17. Zhang Y, Wang C, Wang H, Wang K, Du Y and Zhang J: Combination of tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo. Cancer Lett 304: 21-32, 2011.
18. Liu C, Gong K, Mao X and Li W: Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. Int J Cancer 129: 1519-1531, 2011.
19. Li X, Su B, Liu R, Wu D and He D: Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells. J Surg Res 166: e45-51, 2011.
20. Lima RT, Busacca S, Almeida GM, Gaudino G, Fennell DA and Vasconcelos MH: MicroRNA regulation of core apoptosis pathways in cancer. Eur J Cancer 47: 163-174, 2011.
21. Fernandez-Luna JL: Regulation of pro-apoptotic BH3-only proteins and its contribution to cancer progression and chemoresistance. Cell Signal 20: 1921-1926, 2008.
22. Liang CZ, Zhang JK, Shi Z, Liu B, Shen CQ and Tao HM: Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of Bax and Fas/FasL and downregulation of Bcl-2. Cancer Chemother Pharmacol 69: 317-331, 2011.
23. Ito Y, Pandey P, Sporn MB, Datta R, Kharbanda S and Kufe D: The novel triterpenoid CDDO induces apoptosis and differentiation of human osteosarcoma cells by a caspase-8 dependent mechanism. Mol Pharmacol 59: 1094-1099, 2001.
24. Oh SH and Lee BH: Induction of apoptosis in human hepatoblastoma cells by tetrandrine via caspase-dependent Bid cleavage and cytochrome c release. Biochem Pharmacol 66: 725-731, 2003.
25. Shukla RK, Kumar A, Gurbani D, Pandey AK, Singh S and Dhawan A: TiO2 nanoparticles induce oxidative DNA damage and apoptosis in human liver cells. Nanotoxicology 7: 48-60, 2013.
26. Kaseta MK, Khaldi L, Gomatos IP, et al: Prognostic value of bax, bcl-2, and p53 staining in primary osteosarcoma. J Surg Oncol 97: 259-266, 2008.
27. Cao X, Bennett RL and May WS: c-Myc and caspase-2 are involved in activating Bax during cytotoxic drug-induced apoptosis. J Biol Chem 283: 14490-14496, 2008.
28. Schmitz I, Kirchhoff S and Krammer PH: Regulation of death receptor-mediated apoptosis pathways. Int J Biochem Cell Biol 32: 1123-1136, 2000.
29. Luo X, Budihardjo I, Zou H, Slaughter C and Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490, 1998.
30. Liu X, Kim CN, Yang J, Jemmerson R and Wang X: Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157, 1996.
31. Wang K, Yin XM, Chao DT, Milliman CL and Korsmeyer SJ: BID: a novel BH3 domain-only death agonist. Genes Dev 10: 2859-2869, 1996.